New diabetes drug may offer fewer injections, weight loss

"A once-a-week injectable diabetes drug appears to lower blood sugar somewhat better than the same drug injected twice daily, creating promise that the new formulation may be a more useful part of a Type 2 diabetes control regime, a new study suggests. The drug, exenatide, also has the advantage of triggering modest weight loss - an average of just over 3.5 kilograms - in people taking it, making it the only available diabetes drug to do so. While some diabetes drugs are 'weight-neutral,' most cause weight gain, which can complicate diabetes control and undermine a person's willingness to take their medication. The results of the study were published Monday by the journal The Lancet to coincide with their release at a scientific meeting in Rome" - Winnipeg Free Press